Sample BPA Call Order - Attachment 2.xlsx
XLSX spreadsheet 15 KB Posted
- Solicitation number
- 15DDHQ24R00000021
About this file
This document is a Sample BPA Call Order that provides contractors with DEA's projected annual estimates to be ordered against a Blanket Purchase Agreement (BPA). The purpose is to obtain pricing from contractors for various pharmacological studies to evaluate the abuse potential of hallucinogenic substances, including drug discrimination, pharmacokinetic, and locomotor assays. Contractors must provide pricing on an "all or none basis" for the entire set of sample work, which will be used to determine the proposed fixed rates in the Pricing Sheet. The related federal contract opportunity is for the "Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies" on behalf of the Drug Enforcement Administration.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Attachment 2 - Sample BPA Call
ATTACHMENT 2: SAMPLE BPA CALL ORDER
The purpose of this BPA Call Order is to provide contractors DEA’s projected annual estimates to be ordered against the BPA.
(FOR PRICING PURPOSES ONLY)
Proposals that do not include pricing in the Sample BPA Call Order in its entirety (“all or none basis”) will not be reviewed by the government.
The completed Sample BPA Call Order shall be submitted with the contractor’s Cost Proposal. The proposed fixed rates from the Sample BPA Call Order shall be identical to the proposed fixed rate in the Pricing Sheet. Contractors shall provide a sample Call Order for Ordering Period 1 only.
The contractor shall propose a single loaded rate per Contract Line Item Number (CLIN) that includes direct labor, overhead, fringe, general and administrative expenses (G&A), and profit. The contractor must verify the calculated totals per labor category, by year, and the grand total for all years.
Title: Evaluation of Abuse Potential of Hallucinogenic Substances Using In Vivo Pharmacological Studies
| Agency: | Drug Enforcement Administration |
| ORDERING PERIOD 1 |
| CLIN Line Item | Assay | Quantity | Unit | Unit Price | Estimated Total Price |
| 0001 | Drug Discrimination (initial training) - Drug 1 - Assay Cost | 1 | EA | 0.00 | |
| 0002 | Drug Discrimination (initial training) - Drug 1 - Incidental Cost | 1 | EA | 0.00 | |
| 0003 | Drug Discrimination (initial training) - Drug 2 - Assay Cost | 1 | EA | 0.00 | |
| 0004 | Drug Discrimination (initial training) - Drug 2 - Incidental Cost | 1 | EA | 0.00 | |
| 0005 | Drug Discrimination (monthly maintenance of training drug) - Drug 1 - Assay Cost | 1 | EA | 0.00 | |
| 0006 | Drug Discrimination (monthly maintenance of training drug) - Drug 1 - Incidental Cost | 1 | EA | 0.00 | |
| 0007 | Drug Discrimination (monthly maintenance of training drug) - Drug 2 - Assay Cost | 1 | EA | 0.00 | |
| 0008 | Drug Discrimination (monthly maintenance of training drug) - Drug 2 - Incidental Cost | 1 | EA | 0.00 | |
| 0009 | Drug Discrimination of Test Drug - Assay Cost | 1 | EA | 0.00 | |
| 0010 | Drug Discrimination of Test Drug - Incidental Cost | 1 | EA | 0.00 | |
| 0011 | Pharmacokinetic Assay - Assay Cost | 1 | EA | 0.00 | |
| 0012 | Pharmacokinetic Assay - Incidental Cost | 1 | EA | 0.00 | |
| 0013 | Locomotor or another dose-finding assay (if applicable) - Assay Cost | 1 | EA | 0.00 | |
| 0014 | Locomotor or another dose-finding assay (if applicable) - Incidental Cost | 1 | EA | 0.00 | |
| 0015 | Drug Cost Not to Exceed | 1 | EA | $500.00 | 500.00 |
| TOTAL COST ($) | $500.00 |
File details come from the government source that posted it. Updated .